2 Kingdom Street
London W2 6BD
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit www.astrazeneca.com.
Tullastr. 8 - 12
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research. We are more than 30,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. For more information, please visit www.bd.com
8 Calthorpe Road
Binding Site, a specialist protein company, is committed to improving patient care through the development of innovative diagnostic assays. For many years, Binding Site has been producing high quality products for the investigation of immunodeficiency and the measurement of specific antibody response to vaccination.
The VaccZyme™ product range offers ELISA kits for the measurement of specific IgG against Tetanus, Diphtheria, Hib, Salmonella typhi Vi and VZV. We also have kits for measuring specific IgG, IgG2, IgA and IgM response to PCP (Pneumovax™).
Immunoglobulin, IgG/IgA subclass and complement assays are available on our automated turbidimetric analysers, SPAPLUS®and Optilite®.
Chemin de l'Orme
A world leader in in vitro diagnostics for more than 50 years, bioMérieux presents FilmArray®*, BioFire's innovative molecular diagnostic platform enabling syndromic approach of infectious diseases. This system combines speed, accuracy, ease-of-use and comprehensiveness (up to 27 different pathogens in one single assay). FilmArray® is particularly suited for emergency and critical care. By delivering faster results to clinicians in about 1 hour, FilmArray® contributes to improving patient care and reducing healthcare spending.
FilmArray® tests for Upper Respiratory Tract Infections (RP panel), Gastrointestinal Infections (GI panel) and Bloodstream Infections (BCID panel), all CE-marked and FDA-cleared. Available later this year, ME panel for Meningitis and Encephalitis testing.
* multiplex fully automated PCR system (CE-marked and FDA-cleared)
European Society of Paediatric Infectious Diseases
ESPID c/o Kenes International Organizers of Congresses S.A.,
Piet Heinkade 55
European Society of Paediatric Infectious Diseases aims promote the exchange of information among people who have special experience in the field of paediatric infectious diseases (by organizing regular scientific meetings, forming international study groups and networks, participation in advisory boards of other societies, organization of symposia at other international congresses, and through joint publications by members' publications in the Pediatric Infectious Diseases Journal and other journals
rue Fleming 20, Parc de la Noire Epine,
GSK is a world's leading vaccine company, involved in vaccine research, development and production. We have 14 candidate vaccines in development and our broad portfolio of over 30 vaccines prevent illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis. Globally, we have more than 12,000 people working to deliver vaccines safely, every day, to people in 90% of the world's countries. In 2014 we distributed around 800 million doses of vaccine, 80% of them to least developed, low and middle income countries.
For further information, please visit www.gsk.com.
Meridian Bioscience International Limited
16 Edge Business Centre
London, NW2 6EW
Meridian Bioscience manufactures diagnostic kits for the early diagnosis of gastrointestinal, respiratory, sexually transmitted and neonatal infections. Our diagnostic tests aid clinicians in the appropriate management of patients with infectious disease.
New products include illumigene® molecular assays for the detection of Chlamydia and Gonnorhea. New Immunoassays include TRU STREP PNEUMO® for simplifying your strep pneumo rapid testing and the next generation in H. pylori rapid testing, ImmunoCard STAT!® HpSA® HD, a High Definition rapid test from the leaders in stool antigen testing.
Speak with our experts and learn how illumigene® can benefit your laboratory, your budget and your healthcare setting.
350 Massachusetts Avenue
Bexsero is licensed in 37 countries, including the EU, Canada, Australia and most recently the US (January 2015). More than one million doses of Bexsero have shipped to date. Bexsero continues to gain endorsement from national health authorities, including the UK Joint Committee on Vaccination and Immunisation (JCVI), whose endorsement will place Bexsero on the UK National Immunisation Programme in 2015. Bexsero has also been used in a regional vaccination program in Canada
OM Pharma / Vifor Pharma
PO. Box 88
22, rue du Bois-du-Lan
CH-1217 Meyrin / Geneva
OM Pharma, a company belonging to Vifor Pharma, is a world leader in immunoactive therapies. Its leading brand, Broncho-Vaxom®, is indicated in the prevention of respiratory tract infections in adults and children. Vifor Pharma is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. Headquartered in Zurich, Switzerland, Vifor Pharma has an increasingly global presence and a broad network of affiliates and partners around the world.
For more information about OM Pharma and Vifor Pharma, please visit www.viforpharma.com
23-25 Av. du Dr. Lannelongue
Rives de Paris ,75014
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
Sanofi Pasteur MSD
162 acvenue Jean Jaures
Building upon the legacy of pioneers like Louis Pasteur we want to help protect people against infectious diseases so that they can live longer, feel better and achieve more. We are dedicated exclusively to vaccines because we believe prevention is better than cure and immunisation is the best prevention.
Our 45 vaccines help protect people from 20 infectious diseases, including cervical cancer, liver cancer, tuberculosis, poliomyelitis, rabies, measles, yellow fever, shingles and influenza. Our vaccines help protect everyone throughout life –from infancy to old age.
Sanofi Pasteur MSD is a joint venture between sanofi pasteur - the vaccine division of sanofi-aventis - and Merck & Co. Inc.. We develop, license, market and distribute vaccines in Western Europe. We lead the vaccine industry in Western Europe.
Statens Serum Institut
2300 Copenhagen S
Statens Serum Institut (SSI) is a public enterprise under the Danish Ministry of Health. For more than 100 years SSI's main task has been to secure the preparedness towards infectious diseases and congenital disorders. The tasks have been expanded, and today, SSI is a highly regarded and recognized national and international research, production and service enterprise.
SSI's tasks include: research-based health surveillance; rational use of IT in the Danish healthcare system; ensuring the supply of vaccines and other biological products and diagnostic services through production and procurement; prevention and control of infectious diseases, biological threats and congenital disorders; preparedness against biological terrorism.
University of Oxford
Oxford Vaccine Group,
Department of Paediatrics, CCVTM, Churchill Hospital,
Oxford OX3 7LE
Hot Topics In Infection And Immunity In Children, The ESPID-Oxford Course
Hot Topics In Infection And Immunity In Children, The ESPID-Oxford Course, aims to provide both basic information and updates in key areas of paediatric infectious disease. It is held in Oxford, UK each summer, with 30 leading experts from around the world, providing updates on the latest developments in the field. It is also a residential component of the ESPID-Oxford Postgraduate Diploma in PID.
Wisepress Medical Bookshop
25 High Path, Merton Abbey
London, SW19 2JL, UK
Wisepress.com, Europe's leading conference bookseller, has a complete range of books and journals relevant to the themes of the meeting. Books can be purchased at the stand or, if you would rather not carry them, posted to you – Wisepress will deliver worldwide. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers.